Hepatitis C prevalence reaches 2% of US population:
This article was originally published in Clinica
Executive Summary
Hepatitis C has become the most chronic blood borne infection in the US with prevalence reaching 1.8% of the population, according to the country's third National Health and Nutrition Examination Survey. The survey, reported in the August 19 issue of the New England Journal of Medicine, indicates that 3.9 million people have hepatitis C infection with almost 70% of this figure chronically infected. The strongest factors associated with infection are illegal drug use and high-risk sexual behaviour. Between 8,000 and 10,000 deaths occur annually from liver complications associated with hepatitis C, says the survey.
You may also be interested in...
Boehringer Ingelheim Overtakes Bayer As Germany’s Biggest Pharma Company
The privately owned company is searching for a successor to Jardiance, while the outcome of US Inflation Reduction Act talks on price cuts to the blockbuster will be revealed in September.
Synthekine Joins Quest To Tame IL-2 In Cancer Therapies
First clinical data from Synthekine’s IL-2 candidate and that ofrivalsMedicennawere presented at the AACR, suggesting there’s life in the modality yet.
Swisse Supplements Take Bigger Slice Of Chinese Market
Australian-heritage Swisse grew its share of China's supplements market in 2023 by delivering tailored products to an increasingly health conscious population.